Equifax (EFX) Earnings Analysis
Equifax (EFX) next reports earnings on 2026-10-20, consensus EPS 2.25 USD. Last quarter (2026-07-21) it beat with EPS 2.25 USD vs 2.2 USD est (+2.3%). It has beaten estimates in 6/6 recent quarters (100%). Trailing P/E 24.49.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does EFX next report earnings?
| Next earnings date | 2026-10-20 |
|---|---|
| Consensus EPS estimate | 2.25 USD |
| Revenue estimate | 1.70B |
EFX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-07-21 | 2.25 USD | 2.2 USD | +2.3% | Beat |
| 2026-02-04 | 2.09 USD | 2.06 USD | +1.5% | Beat |
| 2025-10-21 | 2.04 USD | 1.94 USD | +5.2% | Beat |
| 2025-07-22 | 2 USD | 1.93 USD | +3.6% | Beat |
| 2025-02-06 | 2.12 USD | 2.12 USD | 0% | Beat |
| 2024-10-16 | 1.85 USD | 1.85 USD | 0% | Beat |
Beat rate: 6/6 (100%) over reported quarters with consensus data.
EFX valuation and analyst view
| Trailing P/E | 24.49 |
|---|---|
| Trailing EPS | 5.839 USD |
| Price / book | 4.61 |
| Dividend yield | 1.24% |
| Market cap | 20.20B |
| Analyst consensus | Buy (23 buy / 11 hold / 1 sell) |
| Avg price target | 209.67 USD |
Related research pages
Frequently asked questions
When is Equifax (EFX)'s next earnings date?
Equifax is next scheduled to report on 2026-10-20, with a consensus EPS estimate of 2.25 USD and revenue estimate of 1.70B.
Did EFX beat earnings last quarter?
In its 2026-07-21 report, EFX posted EPS of 2.25 USD versus a 2.2 USD estimate — a beat of 2.3%.
What is EFX's earnings track record?
Over the last 6 reported quarters with consensus data, EFX beat estimates 6 times (100%).
What is EFX's current P/E ratio and EPS?
EFX trades at a trailing P/E of 24.49 on trailing EPS of 5.8386824324324325 USD.
What do analysts rate EFX?
Analyst consensus is "Buy" across 35 ratings (0 strong buy, 23 buy, 11 hold, 1 sell, 0 strong sell). Average 12-month price target: 209.67 USD.